Status of the collagen metabolism and intracardiac hemodynamics in patients with mitral valve prolapse and diabetes mellitus type 1

  • Olena Nikolenko V. N. Karazin Kharkiv National University School of Medicine
  • Ivan Smirnov Candidate of Medical Sciences
Keywords: mitral valve prolapse, diabetes mellitus, free and peptide-bound oxyproline, heart valves degeneration, echocardiographic parameters of intracardiac hemodynamics


Summary. Mitral valve prolapse is a significant cardiovascular risk factor in young adults. Its combination with type 1 diabetes mellitus can influence the nature and development of the disease.

Objective – a comparative analysis of free and peptide-bound oxyproline levels and basic echocardiographic parameters (ECP) in patients with mitral valve prolapse, type 1 diabetes and their combination.

Materials and methods – 93 people aged 19–33 years were examined, including 24 people with mitral valve prolapse without concomitant pathology; 33 patients with mitral valve prolapse and type 1 diabetes; 36 patients with type 1 diabetes without mitral valve prolapse.

Results. The level of free and peptide-bound oxyproline in blood serum and their ratio were assessed as a marker of collagen metabolism. The levels of free oxyproline were significantly higher only for the group of MVP patients with type 1 diabetes (p < 0.05) compared to the control group. Severity of destructive processes was demonstrated by a high level of peptide-bound oxyproline, both in combined pathology compared with control group, and compared with groups of patients with monomorbid diabetes and MVP (p < 0.05). In patients with mitral valve prolapse and type 1 diabetes for more than 10 years in anamnesis were found significant differences in the echocardiography parameters (ventricular septum thickness, posterior wall of the left ventricle thickness) compared with the subgroup of patients with less than 10 years of type 1 diabetes in anamnesis and the group with isolated mitral valve prolapse.

Conclusions. The data obtained indicate an aggravation in collagen metabolism disorders in patients with mitral valve prolapse depending on the duration of type 1 diabetes, and demonstrate the effect of carbohydrate metabolism disorders on the risk of developing connective tissue degradation of the heart valve apparatus.


Download data is not yet available.

Author Biographies

Olena Nikolenko, V. N. Karazin Kharkiv National University School of Medicine

Assistant at the Department of General Practice - Family Medicine, V. N. Karazin Kharkiv National University, 6, Svobody Sq., Kharkiv, Ukraine, 61022

Ivan Smirnov, Candidate of Medical Sciences

Head of the Endocrinology Department CNС KhRC  «Regional Clinical Hospital», Candidate of Medical Sciences, Trinklera street, 6, Kharkiv, Ukraine, 61000


Zemtsovskyy EV, Tymofeev EV, Malev EG. Hereditary disorders (dysplasia) of connective tissue. Which of the two current national recommendations is preferable?. Pedyatr. 2017;8(4):6–18.

Kadurina TI, Gorbunova VN. 2009. Connective tissue dysplasia. Guideline for doctors. SPb, ELBI; 714.

Pavlov SB, Pavlova GB. Study the role of intercellular mediators in the metabolism of connective tissue in children with cardiomyopathy and osteopeny. Journal of Education, Healthand Sport. 2016;6(9):902-916.

Clinical guidelines of the Russian Scientific Medical Society of Physicians for the diagnosis, treatment and rehabilitation of patients with connective tissue dysplasia (first revision). Medical Bulletin of the North Caucasus. 2018;13;1-2:137-209. https: // 2018.13037

Pavlov SB, Zukow W. Violation of collagen metabolism in the development of renal scarring in patients with chronic pyelonephritis. Journal of Education, Health and Sport. 2016;6(6):263-278.

Sharaev PN, Sakhabutdinova EP, Lekomtseva OI, Koshikova SV. Determination of free and peptide-bound hydroxyproline in blood serum. Clinical laboratory diagnostics. 2009;1:7-9.

Furtseva LN. Biochemistry of bone and cartilage tissue. Actual problems of theoretical and clinical osteoarthrology. [Ed. Yu.I. Denisov-Nikolsky, S.P Mironov, Y.P Omelianenko, I.V Matveychuk]. M .: JSC "Printing House" News ", 2005;336.

Klemenov AV. Mitral valve prolapse: modern concepts and unresolved issues (review). Modern technologies in medicine. 2017;9;3:126-137. / stm. 2017.9.3

International classification of diseases 10th revision (ICD-10).

Bayer-Topilsky T, Suri RM, Topilsky Y, Marmor YN, Trenerry MR, Antiel RM, Mahoney DW, Schaff HV, Enriquez-Sarano M. Mitral Valve Prolapse, Psychoemotional Status, and Quality of Life: Prospective Investigation in the Current Era. Am. J. Med. 2016; 129 (10): 1100–9.

Mecarocci V, Mori F. P210 Long-term outcome of primary mitral valve prolapse: results from a population of 250 patients referred to a tertiary cardiovascular center. Eur. Heart J. Cardiovasc. Imaging. 2016; 17 (2): 1129–1137.

Nalliah CJ, Mahajan R, Elliott AD, Haqqani H, Lau DH, Vohra JK, Morton JB, Semsarian C, Marwick T, Kalman J.M, Sanders P. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis. Heart. 2019;105(2):144-151.

Clavel MA, Mantovani F, Malouf J, Michelena HI, Vatury O, et al. Dynamic phenotypes of degenerative myxomatous mitral valve disease: quantitative 3-dimensional echocardiographic study. Circ Cardiovasc Imaging. 2015;8(5):e002989.

Kitkungvan D, Nabi F, Kim RJ, Bonow RO, Khan MA, Xu J, Little SH, Quinones MA, Lawrie GM, Zoghbi WA, Shah DJ. Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse. J. Am. Coll. Cardiol. 2018; 72 (8): 823–834.

Bui AH, Roujol S, Foppa M, Kissinger K.V, Goddu B, et al. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. Heart. 2017; 103: 204–9.

Muehrcke DD, Cosgrove DM. Mitral valvuloplasty. Edmunds Jr LH, ed. Cardiac surgery in the adult. New York: McGraw Hill, 1997, p. 991.

Perazzolo Marra M, Basso C, De Lazzari M, Rizzo S, Cipriani A, et al. Morphofunctional Abnormalities of Mitral Annulus and Arrhythmic Mitral Valve Prolapse. Circ Cardiovasc Imaging. 2016; 9 (8):e005030.

Alimova IL, Pashinskaya NB, Pleskachevskaya TA. Features of type 1 diabetes mellitus in children and adolescents with connective tissue dysplasia. Medical Bulletin of the North Caucasus. 2016; 2 (2): 272–275.[Russian]

Chernyshova TE, Kournikova IA, Maslova IS. Connective tissue dysplasia: predictive value in diabetology. Kuban Scientific Medical Bulletin. 2009; 6: 76−79.

Arsentyev VG, Sereda YuV, Tikhonov VV. Dysplasia of connective tissue - the constitutional basis of multiple organ disorders in children and adolescents. Pediatrics. Journal them. G.N. Speransky. 2011; 90; 5: 54−57.

Nakaz MOZ Ukrayiny N 1021 vid 29 grudnya 2014 roku «Pro zatverdzhennya ta vprovadzhennya medyko-tekhnologichnykh dokumentiv zi standartyzatsiyi medychnoyi dopomogy pry tsukrovomu diabeti 1 typu u molodykh lyudey ta doroslykh» [On approval and implementation of medical and technological documents for standardization of medical care for type 1 diabetes in young people and adults]. [Ukrainian]. Available from:

Freed LA, Benjamin EJ, Levy D. et al. Mitral valve prolapse in the general population. The benign nature of echocardiography features in the Framingham Heart Study. J Am CollCardiol. 2002;40(7):1298−1304.

Khvysyuk OM, Pavlov SB, Pavlova GB. On the question of the role of the functional state of connective tissue in the implementation of the systemic response to damage. Problemy bezperervnoyi medychnoyi osvity ta nauky. 2016; 3: 55–61.

How to Cite
Nikolenko, O., & Smirnov, I. (2021). Status of the collagen metabolism and intracardiac hemodynamics in patients with mitral valve prolapse and diabetes mellitus type 1. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine&quot;, (41).